HDAC2 and esophageal squamous cell carcinoma: Supported by a recent research, HDAC2 expression is elevated in ESCC which is closely connected with clinical stage and lymph node metastasis, and HDACs inhibition disrupts ESCC cell progression, ameliorates cancer stemness and impedes tumorigenicity in mice [28].